Postoperative Radioactive Iodine for Differentiated Thyroid Cancer: A Historical Perspective

TW Chan, JR Hurley and TJ Fahey

Department of Surgery, Section of Endocrine Surgery, Weill Cornell Medical College, USA
Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Weill Cornell Medical College, USA

^*Correspondance to: TW Chan 

 PDF  Full Text Review Article | Open Access

Abstract:

Radioactive iodine has been used in differentiated thyroid cancer for postoperative thyroid remnant ablation for several decades, yet its indications remain controversial. Because the potential administration of postoperative RAI plays an important role in surgical decision-making, understanding the current indications for postoperative RAI is critical in the global management of differentiated thyroid cancer. This review examines the changing indications for postoperative radioiodine from its introduction to the current guidelines.

Keywords:

Cite the Article:

Chan TW, Hurley JR, Fahey TJ. Postoperative Radioactive Iodine for Differentiated Thyroid Cancer: A Historical Perspective. Clin Oncol. 2017; 2: 1230.